Identification and characterization of the promoter and upstream regulation region of mouse PD-1

Progress in Biochemistry and Biophysics

Volumn 37, Issue 5, 2010, Pages 527-533

  Zheng, Hua Yang ^a   Tang, Bi Kui ^a,b   Wang, Pei Wei ^a   Gao, Fang Jian ^a   Hu, Xiao Bo ^a   Gong, Li ^a   Zhu, Nai Shuo ^a,b  

^a FUDAN UNIVERSITY   (China)

^b BENGBU MEDICAL COLLEGE   (China)

Author keywords

PD 1; Promoter identification; Transcriptional regulation

Indexed keywords

SIMIAN VIRUS 40;

EID: 77954923015     PISSN: 10003282     EISSN: None     Source Type: Journal    
DOI: 10.3724/SP.J.1206.2009.00664     Document Type: Article

References (18)

1. Ishida Y, Agata Y, Shibahara K, et al. Induced expression of PD-1, a novel member of the immunoglobulin gene superfemily, upon programmed cell death. The EMBO J, 1992, 11(11): 3887-3895
2. Greenwald R J, Freeman G J, Sharpel A H. The B7 family revisited. Annu Rev Immunol, 2005, 23: 515-548
3. Agata Y, Kawasaki A, Nishimura H, et al. Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes. Int Immunol, 1996, 8(5): 765-772
4. Okazaki T, Maeda A, Nishimura H, et al. PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology-domain-containing tyrosinephosphatase to phosphotyrosine. Proc Natl Acad Sci USA, 2001, 98(24): 13866-13871
5. Chemnitz J M, Parry R V, Nichols K E, et al. SHP-land SHP-assosicate with immunoreceptor human T cell stimulation, but only receptor ligation prevents T cell activation. J Immunol, 2004, 173 (2): 945-954
6. Okazaki T, Honjo T. The PD-1-PD-L pathway in immunological tolerance. TRENDS in Immunology, 2006, 27(4): 195-201
7. Peng G P, Li S P, Wua W, et al. PD-1 upregulation is associated with HBV-specific T cell dysfunction in chronic hepatitis B patients. Mol Immun, 2008, 45(4): 963-970
8. Pian Ye, Weng Z H, Zhang S L, et al. Programmed death-1 expression is associated with the disease status in hepatitis B virus infection. World J Gastroenterol, 2008, 14(28): 4551-4557
9. +T cells correlates with the outcome of acute hepatitis B. Gastroenterology, 2008, 134 (7): 2168-2171
10. + regulatory T cell of non-responders after hepatitis B surface antigen vaccine immunization. Clin Immun, 2008, 129(1): 176-177
11. Khoury S J, Sayegh M H. The roles of the new negative T cell co-stimulatory pathways in regulating autoimmunity. Immunity, 2004, 20(5): 529-534
12. + lymphocyte clusters. Eur J Cancer, 2009, 45(9): 1664-1672
13. Day C L, Kaufhlann D E, Kiepiela P, et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disdmprogression. Nature, 2006, 443(7109): 350-354
14. Hirnno F, Kaneko K, Tamura H, et al. Blockade of B7-H1 and PD-1 by monoclonal antibodies potentiates crlcer therapeutic iramunity. Cancer Res, 2005, 65(3): 1089-1096
15. Ding H, Wu X, Wu J, et al. Delivering PD-I inhibitory signal concomitant with blocking ICOS co-stimulation suppresses lupuslike syndrome in autoimmune BXSB mice. Clin Immunol, 2006, 118(2-3): 258-267
16. Eckert R L, Crish J F, Banks J F, et al. The epidermis: geneson-genes off. J Invest Dermatol, 1997, 109(4): 501-509
17. McNagny K M, Sieweke M H, Döderlein G, et al. Regulation of eosinophil-specific gene expression by a C/EBP-Ets complex and GATA-1. EMBO J, 1998, 17(13): 3669-3680
18. Merika M, Orkin S H. Functional synergy and physical interactions of the erythroid transcription factor GATA-1 with the kruppel family proteins Sp1 and EKLF. Mol Cell Biol, 1995, 15(5): 2437-2447